Role of p38 Mitogen-Activated Protein Kinase on Cerebral Vasospasm After Subarachnoid Hemorrhage
- 1 June 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (6) , 1466-1470
- https://doi.org/10.1161/01.str.0000127425.47266.20
Abstract
Background and Purpose— Inflammatory cytokines are involved in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage (SAH). This study was conducted to examine the role of p38 mitogen-activated protein kinase (MAPK) in the development of vasospasm and cytokine production. Methods— We measured the expression levels of genes and proteins related to inflammation in human vascular smooth muscle cells (hVSMCs) treated with hemolysate and FR167653 (FR) (1μmol/L), a selective p38MAPK inhibitor, for 48 hours by TaqMan real-time reverse transcription-polymerase chain reaction (RT-PCR) and ELISA. Twenty-one dogs were assigned to 3 groups of 7 animals: control, placebo, and FR-treated (1 mg/kg/d) groups in a double-hemorrhage model. The effects were assessed through the caliber of the basilar artery, and the changes in gene expressions and the activation of p38MAPK were assessed by Western blot analysis. Results— Treatment of hVSMCs with hemolysate induced significant upregulation of interleukin (IL)-1α, IL-1β, and IL-8 gene and protein expressions, which was suppressed significantly with FR. The mean vessel caliber on day 7, as a percentage of that of day 0, was 49% in the placebo, and 74% in the FR group (P=0.0001). The gene expression levels of IL-1α, IL-1β, and IL-8 in the arterial wall were extremely elevated in the placebo, and significantly suppressed in the FR group (P=0.0027, 0.0002, and 0.0073). p38MAPK phosphorylation was stimulated in the placebo and hemolysate in vitro, and suppressed in the FR group. Conclusions— These results suggest that p38MAPK is activated in the arterial wall after SAH, leading to the development of vasospasm, possibly through the upregulation of inflammatory cytokines.Keywords
This publication has 10 references indexed in Scilit:
- Invited Review: Focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscleJournal of Applied Physiology, 2001
- FR167653 attenuates ischemia and reperfusion injury of the rat lung with suppressing p38 mitogen-activated protein kinaseThe Journal of Heart and Lung Transplantation, 2001
- Effects of MAPK inhibitors on cerebral vasospasm in a dog double hemorrhage modelJournal of Neurosurgery, 2000
- Identification of Genes Differentially Expressed in Canine Vasospastic Cerebral Arteries after Subarachnoid HemorrhageJournal of Cerebral Blood Flow & Metabolism, 1999
- Mitogen-activated protein kinase mediation of hemolysate-induced contraction in rabbit basilar arteryJournal of Neurosurgery, 1999
- The p38 MAP Kinase Pathway and Its Biological FunctionTrends in Cardiovascular Medicine, 1998
- FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-α, ameliorates endotoxin-induced shockEuropean Journal of Pharmacology, 1997
- Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels.The Journal of Immunology, 1997
- Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes.Journal of Clinical Investigation, 1996
- A protein kinase involved in the regulation of inflammatory cytokine biosynthesisNature, 1994